Rentokil Initial upgraded to Outperform from Underperform at Bernstein

Bernstein analyst Will Kirkness double upgraded Rentokil Initial (RTO) to Outperform from Underperform with a price target of 570 GBp, up from 313 GBp, as the firm sees signs of inflecting organic revenue growth. The firm expects organic growth can improve to 3%-5% as the market remains supportive and strategic investments pay off, the analyst tells investors.